FindTrial
Sign In

Exploring Womens Acceptance of Self-Sampling for HPV as a Cervical Cancer Screening Tool

Acceptability of HPV Self-Sampling as a Cervical Cancer Screening Modality: A Cross-Sectional Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085853
Enrollment
60
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R399- Unspecified symptoms and signs involving the genitourinary system

Interventions

Intervention1: Nil: Nil

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women between the age group of 30 and 55 years attending GOPD. 2.Undergoing LBC.

Exclusion criteria

Exclusion criteria: 1.Received treatment for premalignant lesion and cervical cancer. 2.Women who are unwilling to consent. 3.Had a total hysterectomy. 4.Women who are pregnant at the time of sampling 5.Menstruating women at the time of sampling. 6.Women with genitourinary prolapse.

Design outcomes

Primary

MeasureTime frame
To compare the acceptability of HPV self-sampling over conventional method of screening for cervical cancer based on post sampling questionaries responseTimepoint: 8 weeks—

Secondary

MeasureTime frame
To compare the results of HPV self-sampling and LBC reportTimepoint: 12 months—

Countries

India

Contacts

Public ContactDr Manisha Meena

PGIMER , chandigarh

manisha89meena@gmail.com9968568043

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026